Literature DB >> 23402232

Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.

B Mulhern1, D Rowen, J Brazier, S Smith, R Romeo, R Tait, C Watchurst, K-C Chua, V Loftus, T Young, D Lamping, M Knapp, R Howard, S Banerjee.   

Abstract

BACKGROUND: Dementia is one of the most common and serious disorders in later life and the economic and personal cost of caring for people with dementia is immense. There is a need to be able to evaluate interventions in dementia using cost-effectiveness analyses, but the generic preference-based measures typically used to measure effectiveness do not work well in dementia. Existing dementia-specific measures can effectively measure health-related quality of life but in their current form cannot be used directly to inform cost-effectiveness analysis using quality-adjusted life-years as the measure of effectiveness.
OBJECTIVES: The aim was to develop two brief health-state classifications, one from DEMQOL and one from DEMQOL-Proxy, to generate health states amenable to valuation. These classification systems consisted of items taken from DEMQOL and DEMQOL-Proxy so they can be derived from any study that has used these instruments. DATA SOURCES: In the first stage of the study we used a large, clinically representative sample aggregated from two sources: a sample of patients and carers attending a memory service in south London and a sample of patients and carers from other community services in south London. This included 644 people with a diagnosis of mild/moderate dementia and 689 carers of those with mild/moderate dementia. For the valuation study, the general population sample of 600 respondents was drawn to be representative of the UK general population. Households were sampled in urban and rural areas in northern England and balanced to the UK population according to geodemographic profiles. In the patient/carer valuation study we interviewed a sample of 71 people with mild dementia and 71 family carers drawn from a memory service in south London. Finally, the instruments derived were applied to data from the HTA-SADD (Study of Antidepressants for Depression in Dementia) trial. REVIEW
METHODS: This was a complex multiphase study with four linked phases: phase 1 - derivation of the health-state classification system; phase 2 - general population valuation survey and modelling to produce values for every health state; phase 3 - patient/carer valuation survey; and phase 4 - application of measures to trial data.
RESULTS: All four phases were successful and this report details this development process leading to the first condition-specific preference-based measures in dementia, an important new development in this field. LIMITATIONS: The first limitation relates to the lack of an external data set to validate the DEMQOL-U and DEMQOL-Proxy-U classification systems. Throughout the development process we have made decisions about which methodology to use. There are other valid techniques that could be used and it is possible to criticise the choices that we have made. It is also possible that the use of a mild to moderate dementia sample has resulted in classification systems that do not fully reflect the challenges of severe dementia.
CONCLUSION: The results presented are sufficiently encouraging to recommend that the DEMQOL instruments be used alongside a generic measure such as the European Quality of Life-5 Dimensions (EQ-5D) in future studies of interventions in dementia as there was evidence that they can be more sensitive for patients at the milder end of disease and some limited evidence that the person with dementia measure may be able to reflect deterioration. FUNDING: The National Institute for Health Research Health Technology Assessment programme.

Entities:  

Mesh:

Year:  2013        PMID: 23402232      PMCID: PMC4781552          DOI: 10.3310/hta17050

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  56 in total

Review 1.  An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Authors:  Rachael Maree Hunter; Gianluca Baio; Thomas Butt; Stephen Morris; Jeff Round; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

2.  Views of the UK General Public on Important Aspects of Health Not Captured by EQ-5D.

Authors:  Koonal Kirit Shah; Brendan Mulhern; Louise Longworth; M F Janssen
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

Review 3.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

Review 4.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

5.  Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care.

Authors:  Stephanie L Harrison; Lisa Kouladjian O'Donnell; Clare E Bradley; Rachel Milte; Suzanne M Dyer; Emmanuel S Gnanamanickam; Enwu Liu; Sarah N Hilmer; Maria Crotty
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

6.  How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?

Authors:  Elisa Aguirre; Sujin Kang; Zoe Hoare; Rhiannon Tudor Edwards; Martin Orrell
Journal:  Qual Life Res       Date:  2015-07-11       Impact factor: 4.147

7.  A multidomain decision support tool to prevent falls in older people: the FinCH cluster RCT.

Authors:  Philippa A Logan; Jane C Horne; Frances Allen; Sarah J Armstrong; Allan B Clark; Simon Conroy; Janet Darby; Chris Fox; John Rf Gladman; Maureen Godfrey; Adam L Gordon; Lisa Irvine; Paul Leighton; Karen McCartney; Gail Mountain; Kate Robertson; Katie Robinson; Tracey H Sach; Susan Stirling; Edward Cf Wilson; Erika J Sims
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.014

8.  The influence of sleep disruption and pain perception on indicators of quality of life in individuals living with dementia at home.

Authors:  Nancy Hodgson; Laura N Gitlin; Jin Huang
Journal:  Geriatr Nurs       Date:  2014-09-02       Impact factor: 2.361

9.  Tibial nerve stimulation compared with sham to reduce incontinence in care home residents: ELECTRIC RCT.

Authors:  Joanne Booth; Lorna Aucott; Seonaidh Cotton; Bridget Davis; Linda Fenocchi; Claire Goodman; Suzanne Hagen; Danielle Harari; Maggie Lawrence; Andrew Lowndes; Lisa Macaulay; Graeme MacLennan; Helen Mason; Doreen McClurg; John Norrie; Christine Norton; Catriona O'Dolan; Dawn Skelton; Claire Surr; Shaun Treweek
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

10.  Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT).

Authors:  Linda Clare; Antony Bayer; Alistair Burns; Anne Corbett; Roy Jones; Martin Knapp; Michael Kopelman; Aleksandra Kudlicka; Iracema Leroi; Jan Oyebode; Jackie Pool; Bob Woods; Rhiannon Whitaker
Journal:  Trials       Date:  2013-05-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.